The short answer
PI-RADS is report language that needs context. In prostate MRI reports, it is a scoring system that describes how likely an MRI finding is to represent clinically significant prostate cancer. This page explains the plain-language meaning, limits, likely next questions, and why your care team must interpret it with the rest of your results.
PI-RADS has a specific meaning in prostate MRI reports.
The phrase alone is not the whole diagnosis or treatment plan.
The next step depends on the full report, prior tests, symptoms, and your cancer history.
Ask what the finding changes, what remains uncertain, and when you will review the plan.
Choose how you want to understand this
The full explanation.
A betting line, not a verdict
PI-RADS stands for Prostate Imaging Reporting and Data System. RadiologyInfo, the public education site of the Radiological Society of North America and the American College of Radiology, describes what the radiologist is doing with it. The score reports "how likely it is that a suspicious area is a clinically significant cancer."
Read that carefully. It is a probability statement about one spot on one scan. It is not tissue. No PI-RADS score, high or low, proves or disproves cancer. Only a biopsy does that.
The five categories, in the words used
RadiologyInfo lists the scale exactly:
- PI-RADS 1. "Very low."
- PI-RADS 2. "Low."
- PI-RADS 3. "Intermediate (undetermined)."
- PI-RADS 4. "High."
- PI-RADS 5. "Very High."
Notice the word in parentheses on 3. The system has a built-in shrug. Category 3 is the scan telling you it cannot decide. That is honest, and it is also the hardest score to act on.
What the magnet is actually measuring
A prostate MRI is not one image. RadiologyInfo notes that the technique section of your report may name "special techniques used to measure water molecule motion (water diffusion) and blood flow (perfusion imaging) within the prostate."
That is the core of it. Cancer cells pack more tightly than normal prostate tissue. Tight packing slows the random drift of water molecules, and the diffusion sequence sees that. Tumors also build leaky new blood vessels, so contrast dye washes in fast and washes out fast. The perfusion images see that. The radiologist stacks these signals with anatomy images and turns the pattern into one number.
Why 3 is the decision point
The National Cancer Institute (NCI) states the operating rule in its summary of prostate cancer screening. Men with a "PI-RADS score of 3 or higher for any area of the prostate gland are recommended for MRI-guided biopsy." Men without such a finding "may undergo systematic biopsy alone or be followed up without immediate biopsy."
So the line sits between 2 and 3. A 2 can often be watched. A 3 usually earns a needle, and a 4 or 5 nearly always does.
What "clinically significant" means, and why it moves
This phrase carries the whole scale, and it does not have one fixed definition. NCI reports different cutoffs used in different studies. One Swedish screening trial used a Gleason score above 3+4. A diagnostic biopsy study used Gleason 7 or higher. A single-center study used Gleason 4+3 or higher.
That matters because Gleason 3+4 and 4+3 are both a total of 7, and they behave differently. NCI notes that the score "is often provided by its separate components (e.g., Gleason score 3 + 4 = 7; or 4 + 3 = 7)" because the order carries its own information. The first number is the dominant pattern.
NCI also gives the Grade Group system, which was built to fix exactly this confusion:
- Grade Group 1. Gleason 6 or less.
- Grade Group 2. Gleason 3+4 = 7.
- Grade Group 3. Gleason 4+3 = 7.
- Grade Group 4. Gleason 8.
- Grade Group 5. Gleason 9 or 10.
When you ask what "significant" means in your case, you are really asking which of those groups your team is trying to catch.
What adding MRI actually changed
The case for scanning before biopsy is not that MRI finds more cancer. It is that it finds better cancer and spares needles.
NCI reports a Swedish trial in which "detection rates of clinically significant cancer were 18% in the standard group versus 21% in the experimental group." In the same trial, "biopsy rates were 73% in the standard-treatment group versus 36% in the experimental group." So slightly more of the cancers that matter were caught, using about half as many biopsies.
NCI also cites a single-center study where MRI-directed biopsy "correctly classified 91% of them as clinically significant, while systematic biopsy correctly classified 62%." A meta-analysis it cites found the MRI approach "decreased the chance of biopsies (OR, 0.28)."
Where the number lets people down
NCI's treatment summary supplies the counterweight. A large study found that "MRI-directed biopsies alone led to misclassification of 8.8% of cancers defined as clinically significant."
That is roughly one in eleven. It is why many urologists still take some systematic cores alongside the targeted ones, rather than sampling only the bright spot. If you are offered a targeted-only biopsy, it is fair to ask why.
The other soft spot is the PI-RADS 3 zone. The label says undetermined, and the follow-up varies. Some teams biopsy every 3. Others use PSA density, which divides your PSA by the prostate volume printed in the report, to sort out which 3s to sample. Ask which approach yours uses and what the deciding number is.
Reading the rest of the page
RadiologyInfo notes that a prostate MRI report "commonly includes six sections": type of exam, clinical history, comparison, technique, findings, and "impression (or conclusion)."
Two of those are worth your attention beyond the score. The findings section carries "the size and location of abnormalities (also called lesions)" and whether "the cancer has spread (called staging)." That is where you will see comment on whether tumor appears to reach beyond the prostate capsule, or into the seminal vesicles. Those statements shape surgical planning more than the PI-RADS digit does.
You may also see incidental findings, which RadiologyInfo defines as "abnormalities outside the prostate" that "were not the reason the exam was ordered." A kidney cyst or hip finding may appear. Ask whether any of them need their own follow-up.
RadiologyInfo's closing advice is worth repeating: "You and your doctor will use your report to make decisions about your care. If you have questions your doctor cannot answer, talk to the staff at your imaging facility."
Questions worth asking
Which PI-RADS score was assigned, and where in the gland is the lesion? Is this MRI before biopsy, or after a prior negative one? What definition of clinically significant is my team using? Will the biopsy be targeted only, or targeted plus systematic cores? What is my prostate volume and PSA density? Does the report mention extension beyond the capsule or into the seminal vesicles? If the score is 3, what tips you toward biopsy versus waiting?
Related report help
See the report hub, the report decoder, and Understanding Your Pathology Report.
Sources
Words to know
Tap any term to see what it means.
Common questions
What does PI-RADS mean?
In general, PI-RADS is a scoring system that describes how likely an MRI finding is to represent clinically significant prostate cancer.
Does it mean cancer?
A PI-RADS score is not a biopsy result and does not replace PSA history, exam findings, or pathology.
What should I ask next?
A practical next question is to ask which score was assigned, whether targeted biopsy is recommended, and how the score fits PSA and prior biopsy history.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Look up related pathology, imaging, biomarker, and treatment-response language.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 3 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-20 what this meansLast updated: 2026-08-06Next planned review: 2027-07-20
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share